Dose of Reality: CBO Confirms Big Pharma’s Egregious Prices on Weight Loss Drugs Are Unsustainable

CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY AND NOVO NORDISK

GLP-1 Weight-Loss Leaders “Blow Past” Wall Street Projections in Q4 2023, Read More

BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB AND ABBVIE

More Big Pharma Giants Report Earnings That Top Wall Street Expectations While Read More

BIG PHARMA EARNINGS WATCH: PFIZER & GLAXOSMITHKLINE

Big Pharma Giants Continue Q4 Earnings Besting Wall Street Expectations Pfizer Read More

Advisory: Panel Discussion on Big Pharma’s Patent Abuse with CSRxP Executive Director Lauren Aronson

Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Big Pharma Giant Kicks Off Q4 Earnings After Hiking Prices More Than 40 Times Read More

BIG PHARMA WATCH: AARP REPORT SHINES LIGHT ON SCALE AND COST OF BIG PHARMA’S PRICE HIKES THAT EXCEED INFLATION

Rx Price Watch Analysis Finds Big Pharma Price Increases Outpaced Inflation Read More